Strategies for Setting Occupational Exposure Limits for Engineered Nanomaterials
Project Number1R13OH010337-01
Contact PI/Project LeaderGORDON, TERRY
Awardee OrganizationNEW YORK UNIVERSITY SCHOOL OF MEDICINE
Description
Abstract Text
DESCRIPTION (provided by applicant): Although the study of the toxicity and risks associated with occupational exposure to nanomaterials is moving forward and numerous meetings have addressed the toxicity and risk of exposure to nanoparticles, no meetings have solely addressed the difficulties in setting occupational exposure limits (OELs) for nanomaterials. The proposed meeting will bring together stakeholders from industry, government agencies, non-government organizations, and academics to focus their talents and expertise on developing strategies for assessing safe workplace exposure levels for nanoparticles. We will hold the meeting at George Washington University (GWU) in Washington, DC. GWU is an academic center of excellence that is nationally renowned for research in occupational health and environmental and occupational health policy issues. There will be co- sponsorship by NYU School of Medicine, ACC, GWU, Ferro Corporation, and the 3M Corporation. The goal of the proposed meeting is to bring together and facilitate discussion among key nanomaterial hygienists, risk assessors, and researchers, and it is anticipated that there will be 75 to 100 attendees. While the meeting will focus on nation-wide efforts to develop OELs for nanomaterials, 2 of the invited speakers, Drs. Pauluhn and Lansiedel, will provide a European perspective on OEL setting. The critical issues have been assigned approximately 1/2 day for presentations and discussions. Full participation of stakeholders, speakers, moderators, and audience is expected and appropriate time for questions, answers, and discussion has been allocated for each session. As a final product of the proposed meeting, a published report will include an overview of the workshop, areas of general consensus and disagreement, and areas needing further research. We anticipate that this report will become a 'state of the science' article with recommendations for the best approaches to developing OELs for diverse nanomaterials with varying degrees of support from toxicity data.
PUBLIC HEALTH RELEVANCE: The proposed meeting will bring together stakeholders from industry, government agencies, non- government organizations, and academics to focus their talents and expertise on developing strategies for assessing safe workplace exposure levels for nanoparticles. The meeting will take place in Washington, DC and has a number of co-sponsors. Participation by stakeholders, speakers, and moderators will result in a published report that will provide a 'state of the science' approach (es) to developing safe exposure limits for workplace exposure to nanomaterials. )
Public Health Relevance Statement
The proposed meeting will bring together stakeholders from industry, government agencies, non- government organizations, and academics to focus their talents and expertise on developing strategies for assessing safe workplace exposure levels for nanoparticles. The meeting will take place in Washington, DC and has a number of co-sponsors. Participation by stakeholders, speakers, and moderators will result in a published report that will provide a 'state of the science' approach (es) to developing safe exposure limits for workplace exposure to nanomaterials. )
National Institute for Occupational Safety and Health
CFDA Code
262
DUNS Number
121911077
UEI
M5SZJ6VHUHN8
Project Start Date
01-July-2012
Project End Date
30-June-2013
Budget Start Date
01-July-2012
Budget End Date
30-June-2013
Project Funding Information for 2012
Total Funding
$19,700
Direct Costs
$19,700
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2012
National Institute for Occupational Safety and Health
$19,700
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R13OH010337-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R13OH010337-01
Patents
No Patents information available for 1R13OH010337-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R13OH010337-01
Clinical Studies
No Clinical Studies information available for 1R13OH010337-01
News and More
Related News Releases
No news release information available for 1R13OH010337-01
History
No Historical information available for 1R13OH010337-01
Similar Projects
No Similar Projects information available for 1R13OH010337-01